Top member reports
Company Report
Last edited 2 years ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#14
Performance (59m)
16.7% pa
Followed by
216
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#ASX Announcements
stale
Added 2 years ago

Healius rejects takeover offer from ACL

No surprises given that it was all scrip with hardly any premium

Bit of an overreation in the share price today.

d8894af8f838a4cd040366b8723408e48ffa3d.png

[held]

#History
stale
Added 2 years ago

Nearly got the call correct... Article from the Australian 30 Jan 23

d2717a13b0311fc9bd8dc730a2002ee107a1d7.png

Frankly was surprised by the David V Goliath move from ACL. And more surprised the price held up today.

[held]

#ASX Announcements
stale
Added 2 years ago

Escrow shares sold 22 February.

Probably explains the dump on the 22 February to $3.18 before the share price recovered.

See announcement below regarding Escrow shares.

Would be interesting to see who bought those shares.


be7878aea577689f8e89d21030e172f4035d51.png

a3fceffca6d4d2a4d3d19137586cc6181c46eb.png

[held]

#Financials
stale
Added 2 years ago

Adding to the last straw some of my thoughts

Covid revenue declined 83% on PCP (271=>45)

Non Covid (BAU) revenue up 18% on PCP (305=> 258)

Total revenue down 33.9% on PCP (1hfy22) (529=>350)

So I guess maybe we are starting to see some normalization ex covid revenue of around 350m if non-covid side keeps growing at double digit rates.

Not sure what to make of this though - increase in borrowing from FY22 to 65.9m

ab8b6b4c01838346545f5d2d12b7cf8182f82d.png

I was sure that Crescent capital certainly wouldn't offload at $3, but maybe after this 10% spike they will. Think the share price might have overdone itself today.

Was too late adding to the Strawman.

[held]


#Bull Case
stale
Added 2 years ago

Although Crescent Capital's shares are coming out of escrow, I'm going on the record and cast doubt if they will sell any more as claimed by @ValueDownunder

32e81e461cd594f5f36ab8b765b18c833887c8.png

Crescent released 2 announcements on 12-aug-22 so it is likely everyone got their communication mixed up. So everyone focused on the second letter and not the first shown above.

But then again, anything is possible with private equity.

Looks really cheap now.

#ASX Announcements
stale
Last edited 2 years ago

Pretty much old news. NED (Non executive director) selling

983d95b7eecce566b9e8b772ab6e6b3ce91950.png

[H]

#Financials
stale
Added 2 years ago

Over the last 2 days, ACL share price dropped on release of the FY22 results which appear to be below expecations.

Margin fell to 17.2% for 2HFY22. A big drop from 1HFY22.

Also earnings will come down by a large margin in the future (almost halved from last period - see the second image)

Seems like non covid earnings will grow but at slower rate.

Only positive was large dividend payout of 41c (taking total full year div of 53c). EPS of 88c (as highlighted before). So overall payout of 60% for the full year.

[Held]

a3ec455460d68ac3993153cd64670b217c75fd.png

b643efad511f1e473b5f61bceb45ab2964aa7f.png

#Bull Case
stale
Added 2 years ago

Noticed an increase in PCR testing for Victoria for Covid and the new variant is now making headlines. Haven't checked other states though.

Plus lots of talk of a rough flu season.

Have started buying on that thesis and the fact that price seems to have bottomed.

Held